Related references
Note: Only part of the references are listed.Vaccines against Lyme Disease: What Happened and What Lessons Can We Learn?
Gregory A. Poland
CLINICAL INFECTIOUS DISEASES (2011)
A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses
Chen-Yi Chiang et al.
PLOS ONE (2011)
Rapid isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis
Yan Kwok et al.
PROTEOMICS (2011)
Immunotherapy for Cervical Cancer Research Status and Clinical Potential
Jun-Han Su et al.
BIODRUGS (2010)
A Critical Role for Mast Cells and Mast Cell-Derived IL-6 in TLR2-Mediated Inhibition of Tumor Growth
Sharon A. Oldford et al.
JOURNAL OF IMMUNOLOGY (2010)
A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide
Chih-Hsiang Leng et al.
MOLECULAR IMMUNOLOGY (2010)
Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity
Olivier Renaudet et al.
PLOS ONE (2010)
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
Daniel E. Speiser et al.
SEMINARS IN IMMUNOLOGY (2010)
Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer
Aziz Alami Chentoufi et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design
Hsin-Wei Chen et al.
VACCINE (2009)
The human papillomavirus E7 oncoprotein
Margaret E. McLaughlin-Drubin et al.
VIROLOGY (2009)
Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer
Aziz Alami Chentoufi et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Self-adjuvanting lipopeptide vaccines
Peter M. Moyle et al.
CURRENT MEDICINAL CHEMISTRY (2008)
AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention
Tino F. Schwarz
EXPERT REVIEW OF VACCINES (2008)
Robust immune responses elicited by a fully synthetic three-component vaccine
Sampat Ingale et al.
NATURE CHEMICAL BIOLOGY (2007)
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide
Mi Sun Jin et al.
CELL (2007)
Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A
Tatiana Gartner et al.
IMMUNOLOGY LETTERS (2007)
The perfect mix: recent progress in adjuvant research
Bruno Guy
NATURE REVIEWS MICROBIOLOGY (2007)
Cutting edge: TLR2 directly triggers Th1 effector functions
Takayuki Imanishi et al.
JOURNAL OF IMMUNOLOGY (2007)
The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses
Kazuto Kiura et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response
Ilham Bettahi et al.
VIRAL IMMUNOLOGY (2006)
Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever
Henriette Rau et al.
VACCINE (2006)
Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor
X Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer
ZR Cui et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model
C Schneider et al.
GUT (2004)
ISCOMATRIX™ adjuvant:: an adjuvant suitable for use in anticancer vaccines
TJ Stewart et al.
VACCINE (2004)
Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu
CC Lin et al.
MOLECULAR THERAPY (2004)
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
S Hallez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Lipopeptide epitopes extended by an Nε-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity
XM Zhu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Intratracheal macrophage-activating lipopeptide-2 reduces metastasis in the rat lung
K Shingu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Lipopeptide vaccines - yesterday, today, and tomorrow
L BenMohamed et al.
LANCET INFECTIOUS DISEASES (2002)
Share Paper
